Harrow registers Phase 3 trial of TRIESENCE for pain and inflammation after eye surgerySep 22Trial updateHarrow Inctriamcinolone acetonide
Harrow reports Q2 2026 results, reiterates full-year guidance, cites pipeline progressAug 10Quarterly updateHarrow Inc
Sign inSign in